Researchers at the University of Colorado Anschutz Medical Campus have uncovered a promising breakthrough in the <a ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...

Does CBD oil for pain really work? Learn more here about the best products on the market and the evidence behind cannabinoids ...

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.

Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the ...

The global cannabis pharmaceuticals market is poised for exponential growth, with projections indicating an increase from $3.46 billion in 2023 to $380.77 billion by 2034. This remarkable expansion, ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Polish medical diagnostics company Diagnostyka has set a maximum price for shares offered in its initial public offering (IPO) at 105 zlotys, valuing the offering at up to 1.7 billion zlotys ($416.1 ...

Mum’s had felt like a safe place to process something so life-altering – but my sister’s reaction was heart-wrenching and I ...

CBD products may be everywhere but are consumers and doctors in India accepting them them as truly effective solutions?

The closure of the EOPYY pharmacy on Alexandras Avenue and the intervention of the Minister of Health with... a locksmith ...